Patent · US Active

Xenograft soft tissue implants and methods of making

US10076543B2 · kind B2 · utility

21Cited by

16References

6Claims

0Family size

Assignee

Tutogen Medical GmbH · DE

Inventors

Arnd Wilhelmi · Forchheim, DE
Silke Schreiner · Erlangen, DE
Jake Michaelson · Gainesville, US
Steven Moore · Holly Springs, US
Jennifer Faleris · Alachua, US
Anne Reinlein · Bamberg, DE

Key dates

Filing date	Mar 15, 2013
Grant date	Sep 18, 2018
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L27/3687
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.